Drugs / Hyabak
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT01156025 Background | Mar 2009 → Feb 2010 | epidemic keratoconjunctivitis | Laboratoires Thea | Completed | No outcome recorded |
| — | NCT05356728 Comparator | Mar 2022 → Jun 2023 | dry eye syndrome | The Norwegian Dry Eye Clinic | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hyabak | “Hyabak® eye drops: 5 times daily from D10 to D30” NCT01156025 ↗ |
| Route | Other | “eye drops” NCT01156025 ↗ |